Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00286117
Status:
COMPLETED
Last Update Posted:
2009-05-01
First Post:
2006-02-02
Brief Title:
ITA - Clinical Study Comparing ARIMIDEX With NOLVADEX in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
1033IT0002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Francisco Sapunar MD - Arimidex Medical Science Director
Old Organization:
AstraZeneca
Collaborators
| Name | Class |
|---|---|
| Institute of Cancer Research United Kingdom | OTHER |